Relievant Medsystems Stock

www.relievant.comHealthcare / Medical DevicesFounded: 2006Funding to Date: $247.66MM

Relievant Medsystems developed a minimally-invasive outpatient procedure aimed at relieving chronic lower back pain. Their procedure, Intracept, focuses on vertebrogenic pain. Relievant Medsystems was founded in 2006 by Rex Peters, Samit Patel, and James Peacock and is headquartered in Minneapolis, MN.

Register To Buy and Sell Shares

For more details on financing and valuation for Relievant Medsystems, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Relievant Medsystems’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Relievant Medsystems.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Relievant Medsystems investors also invested in these private companies


Management Team

Tyler Binney
Chief Executive Officer, President & Board Member
Christopher Geyen
Chief Financial Officer
Rex Peters
Co-Founder & Chief Operating Officer
Ray Baker MD
Chief Medical Officer

Board Members

Alexander Schmitz
Endeavour Vision
Arthur Taylor
Vensana Capital
Brenton Ahrens
Canaan Partners
Ross Jaffe MD
New Enterprise Associates
Jason Lettmann
Morgenthaler Ventures

News Highlights

Boston Scientific to buy chronic back pain therapy maker Relievant
Medical devices maker Boston Scientific (BSX.N) said on Tuesday it would buy private medical tech company Relievant Medsystems for an upfront cash payment of $850 million, gaining access to an FDA-cleared therapy for chronic pain. The Massachusetts-based company is also obliged to pay Relievant additional undisclosed payments based on sales performance over the next three years.
Relievant Medsystems Announces Formal Coverage Recommendation from NASS for Basivertebral Nerve Ablation as a Treatment for Chronic Vertebrogenic Low Back Pain
Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that the North American Spine Society (NASS) issued a formal coverage recommendation supportive of basivertebral nerve (BVN) ablation for the treatment of chronic vertebrogenic low back pain.
Updated on: Apr 23, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.